Part,  Chapter, Paragraph

  1    I,     2.  2        |               grew by 56% in the period 1997 to 2004 and 26% in the opposite
  2    I,     2.  6        |              students increased between 1997/98 and 2003/04 in virtually
  3    I,     2.  6        |                well as Iceland. Between 1997/98 and 2003/04, the number
  4   II,     4.  1        |             Statistics (Anderson et al, 1997; Kung et al, 2007)4 and
  5   II,     4.  3        |         Anderson R, Kochanek K, et al. (1997): Report of Final Mortality
  6   II,     4.  3        |              World Health Organization (1997): The World Health Report
  7   II,     4.  3        |                 The World Health Report 1997. Conquering suffering, enriching
  8   II,     5.  2.  2    |                 Cardiology (Sans et al, 1997) and Kesteloot (Kesteloot
  9   II,     5.  2.  2    |                et al, 1985; Sans et al, 1997; Kesteloot et al, 2006).
 10   II,     5.  2.  3    |                et al, 1985; Sans et al, 1997; Kesteloot et al, 2006).~
 11   II,     5.  2.  7    |               behalf of the Task Force (1997): The burden of cardiovascular
 12   II,     5.  4.  2    |                  Scotland (Morris et al 1997; Boyle et al 2001), followed
 13   II,     5.  4.  8    |               Newton RW, MacDonald TM. (1997), The diabetes audit and
 14   II,     5.  4.  8    |                 MEMO Collaboration.BMJ. 1997 Aug 30;315(7107):524-8.~Pap L (
 15   II,     5.  5.Int    |             covered mental health since 1997 through specific projects
 16   II,     5.  5.Int(20)|                Public health Programmes 1997-2004. htt m. A list of all
 17   II,     5.  5.  1    |                 the EU was conducted in 1997-98. This “Key Concepts”
 18   II,     5.  5.  1    |           Children up to 6 years of age(1997-99): Early years of life
 19   II,     5.  5.  1    |                Public Health Programmes 1997-2004). Luxembourg: European
 20   II,     5.  5.  1    |               depression in Sweden from 1997 to 2005. Eur Psychiatry
 21   II,     5.  5.  3    |                 syndrome) (Brown et al, 1997; Saha et al, 2007).~Aetiology –
 22   II,     5.  5.  3    |             studies and countries (WHO, 1997). Recent international literature
 23   II,     5.  5.  3    |          countries (e.g. Hovatta et al, 1997); more recent evidence suggests
 24   II,     5.  5.  3    |               Prax 33:105-107.~Brown S (1997): Excess mortality of schizophrenia,
 25   II,     5.  5.  3    |                Peltonen L, Lonnqvist J (1997): Schizophrenia in the gentic
 26   II,     5.  5.  3    |              Health Organization (WHO) (1997): Gender differences in
 27   II,     5.  5.  3    |                2~Eriksson and Koivikko, 1997 (*) /~Sillanpaa, 1973 (*)~
 28   II,     5.  5.  3    |                 4.3 ~Endziniene et al., 1997~Norway ~Children ~MR review
 29   II,     5.  5.  3    |            Lithuania (Endziniene et al, 1997), localization-related epilepsies
 30   II,     5.  5.  3    |               10%)(Eriksson & Koivikko, 1997; Sidenvall et al, 1993;
 31   II,     5.  5.  3    |               1109.0~3.6~Nilsson et al, 1997~U.K.~GP/MF~Incident cohort~
 32   II,     5.  5.  3    |        treatment (Harris & Barraclough, 1997). Antipsychotic drug intake
 33   II,     5.  5.  3    |          studies (ODonogue and Sander, 1997) to 3.5 per 1,000 in incidence
 34   II,     5.  5.  3    |                 to 0.2% (Black and Lay, 1997; Sheth et al, 2004). In
 35   II,     5.  5.  3    |                 1452.~Black AB, Lay NY (1997): Epilepsy and driving in
 36   II,     5.  5.  3    |                 Pauza V, Miseviciene V (1997): Prevalence of childhood
 37   II,     5.  5.  3    |              Eriksson KJ., Koivikko MJ (1997): Prevalence, classification,
 38   II,     5.  5.  3    |               Harris EC, Barraclough B (1997): Suicide as an outcome
 39   II,     5.  5.  3    |                 T, Farahmand BY, et al (1997): Cause-specific mortality
 40   II,     5.  5.  3    |                ODonogue MF, Sander JW (1997): The mortality associated
 41   II,     5.  5.  3    |              from 125 in 1990 to 154 in 1997; and a mean annual incidence
 42   II,     5.  5.  3    |                 Jordanova L, Topalov N (1997): Prevalence of multiple
 43   II,     5.  5.  3    |          Latorre MA, López A, Errea JM (1997): Prevalence of multiple
 44   II,     5.  5.  3    |            Western world countries 19791997. Public Health 118:268283.~
 45   II,     5.  5.  3    |               1988-97): and prevalence (1997): of multiple sclerosis
 46   II,     5.  5.  3    |              been shown (de Rijk et al, 1997) that a change in the diagnostic
 47   II,     5.  5.  3    |                Whetten-Goldstein et al, 1997). This burden of informal
 48   II,     5.  5.  3    |                Alperovitch A, Rocca WA (1997): Prevalence of parkinsonism
 49   II,     5.  5.  3    |                  Cutson T, Schenkman M (1997): The burden of Parkinson 50   II,     5.  6.  3    |               et al, 2001; Hagen et al, 1997) (Figure 5.6.1), explained
 51   II,     5.  6.  3    |                Picavet and van den Bos, 1997). Musculoskeletal pain is
 52   II,     5.  6.  3    |               in older studies (Brooks, 1997) but outcomes have improved
 53   II,     5.  6.  3    |                 and 35% in men (Cooper, 1997; Sernbo and Johnell, 1993).
 54   II,     5.  6.  3    |         determinant of outcome (Cooper, 1997; Sernbo and Johnell, 1993).~ ~
 55   II,     5.  6.  4    |            diagnosis and gender. Norway 1997.~ ~Use of health care services~ ~
 56   II,     5.  6.  6    |                 Med 26:34-43~Brooks PM (1997): MJA Practice Essentials -
 57   II,     5.  6.  6    |               Dis 66(1):34-45~Cooper C (1997): The crippling consequences
 58   II,     5.  6.  6    |               KB, Kvien TK, Bjorndal A (1997): Musculoskeletal pain and
 59   II,     5.  6.  6    |             Picavet HS, van den Bos GA (1997): The contribution of six
 60   II,     5.  7.  1    |                  2003; Esbjorner et al, 1997). Data on renal replacement
 61   II,     5.  7.  3    |               74 m2 ) (Esbjorner et al, 1997). In 2005 the incidence
 62   II,     5.  7.  3    |                 pmarp (Esbjorner et al, 1997).~ ~The prevalence of ESRD
 63   II,     5.  7.  7    |         Esbjorner E, Berg U, Hansson S (1997): Epidemiology of chronic
 64   II,     5.  7.  7    |            Association. Pediatr Nephrol 1997 Aug;11(4):438-42.~Fadrowski
 65   II,     5.  8.  1    |                 2020 (Murray and Lopez, 1997).~ ~The main elements of
 66   II,     5.  8.  3    |                Study (Murray and Lopez, 1997) has estimated that COPD,
 67   II,     5.  8.  7    |                    Murray CJ, Lopez AD (1997): Alternative projections
 68   II,     5.  9.  3    |               UCB Institute of Allergy, 1997), health care providers
 69   II,     5.  9.  7    |               UCB Institute of Allergy (1997): Allergic diseases as a
 70   II,     5.  9.  7    |               health problem in Europe, 1997~ ~Ventura MT (2004): Allergy,
 71   II,     5. 11.  1    |                consultations (Williams, 1997). Most of the major systemic
 72   II,     5. 11.  3    |           pierced ears (T Nakada et al, 1997). In Portugal, contact allergy
 73   II,     5. 11.  3    |                earrings (R Silva et al, 1997). Silver may also cause
 74   II,     5. 11.  3    |              cosmetic allergens in 19951997 and 20002002 in Finland –
 75   II,     5. 11.  3    |         dermatitis, Contact Dermatitis, 1997;36:233236.~SH Nguyen,
 76   II,     5. 11.  3    |              study, Contact Dermatitis, 1997;37(2):78-81.~H Suzuki, Nickel
 77   II,     5. 11.  3    |            rates in the mid-1990s (19931997) are higher in Nordic countries
 78   II,     5. 11.  4    |          Verboom et al, 2002; Williams, 1997). Other costs such as unemployment
 79   II,     5. 11.  6    |             skin impairments (Williams, 1997). It is evident that skin
 80   II,     5. 11.  7    |                of European Union, 19931997. Oxford, UK: Oxford University
 81   II,     5. 11.  7    |                melanoma in Europe, 19531997: Rising trends in incidence
 82   II,     5. 11.  7    |                 212-217.~ ~Williams HC (1997): Dermatology. In: Stevens
 83   II,     5. 11.  7    |                 Radcliffe Medical Press 1997.~ ~Williams H, Svensson
 84   II,     5. 12.  1    |          Hungary in 1990 (Corrao et al, 1997; La Vecchia et al, 1994).
 85   II,     5. 12.  4    |               thereafter (Corrao et al, 1997; La Vecchia, 2001; Ramstedt,
 86   II,     5. 12.  7    |          Torchio P, Arico S, Decarli A (1997): Trends of liver cirrhosis
 87   II,     5. 15.  2    |                which was established in 1997. It contains a list of over
 88   II,     5. 15.  3    |                 France between 1990 and 1997 revealed that these 200
 89   II,     6.  3.  5    |                 100 000 per year before 1997 to less than 10 per 100
 90   II,     6.  3.  5    |                  with two peaks seen in 1997 and 2001. However, recrudescence
 91   II,     6.  3.  5    |               particularly in Poland in 1997 and 2001, in Latvia in 1996
 92   II,     6.  3.  7    |       documented in the Czech Republic (1997) and France (2003) affecting
 93   II,     8.  2.  1    |                50-70) (Roeleveld et al, 1997; Felce et al, 1994).~ ~Prevalence
 94   II,     8.  2.  3    |                1989; Fortnum and Davis, 1997; Johansson and Arlinger,
 95   II,     8.  2.  3    |                5, 1, 2, and 4 kHz (WHO, 1997). The different grades of
 96   II,     8.  2.  3    |               years (Fortnum and Davis, 1997).~ ~Data available from
 97   II,     8.  2.  3    |                     Fortnum H, Davis A (1997): Epidemiology of permanent
 98   II,     8.  2.  3    |            Audiology 33(1):53-9.~ ~WHO (1997): Report on the First Informal
 99   II,     9            |         antenatal care (Olausson et al, 1997).~ ~Figure 9.T1.1. Percentage
100   II,     9            |           Cordier, 1992; Cordier et al, 1997; Dolk and Vrijheid, 2003;
101   II,     9.  1.  1    |                 Caneva MP, Schlaeder G (1997) : La surveillance prenatale
102   II,     9.  1.  1    |              Obstet Biol Reprod (Paris) 1997;26(4):358-66.~ ~Langhoff-Roos
103   II,     9.  1.  1    |           Cnattingius S, Goldenberg RL (1997): Determinants of poor pregnancy
104   II,     9.  1.  1    |               in Sweden. Obstet Gynecol 1997;89(3):451-7.~Platt MJ, Cans
105   II,     9.  1.  2    |         antenatal care (Olausson et al, 1997).~ ~Figure 9.T1.1. Percentage
106   II,     9.  1.  2    |           Cordier, 1992; Cordier et al, 1997; Dolk and Vrijheid, 2003;
107   II,     9.  1.  2    |            Malformations Working Group (1997): “Congenital Malformations
108   II,     9.  3.  1    |             infection (Madeleine et al, 1997). Few EU countries routinely
109   II,     9.  3.  1    |                    Madeleine MM et al, (1997): Co-factors with human
110   II,     9.  3.  1    |             cancer. J Natl Cancer Inst, 1997. 89(20): p. 1516-23~ ~Makino
111   II,     9.  3.  2    |                 al, 2002; Langer et al, 1997; Stephenson et al, 1993).
112   II,     9.  3.  2    |                 Caneva MP, Schlaeder G (1997) : La surveillance prenatale
113   II,     9.  3.  2    |              Obstet Biol Reprod (Paris) 1997;26(4):358-66.~ ~Langhoff-Roos
114   II,     9.  3.  2    |                  2001): Why mothers die 1997-1999: The confidential enquiries
115   II,     9.  3.  2    |           Cnattingius S, Goldenberg RL (1997): Determinants of poor pregnancy
116   II,     9.  3.  2    |               in Sweden. Obstet Gynecol 1997;89(3):451-7.~ ~Philibert
117   II,     9.  3.  3    |        Switzerland (Dubois-Arber et al, 1997). Some data from the national
118   II,     9.  3.  3    |              were not published. In the 1997/1998 HBSC survey, a number
119   II,     9.  3.  3    |                A, Konings E, Paccaud F (1997): Increased condom use without
120  III,    10.  1.  1    |                 King, 1999; King et al, 1997; Melzer et al, 2005). A
121  III,    10.  1.  1    |                hyperphagia (King et al, 1997). In lean people, in long-term
122  III,    10.  1.  1    |          physical activity (King et al, 1997; Melzer et al, 2005; Titchenal,
123  III,    10.  1.  1    |               carbohydrate (King et al, 1997). Highly active children
124  III,    10.  1.  1    |                 King, 1999; King et al, 1997; Parsons et al, 1999; Schmitt
125  III,    10.  1.  1    | physical activity and diet (King et al, 1997). In addition, only few
126  III,    10.  1.  1    |                 balance (Collins et al, 1997; Hart, 2004).~ ~Predisposing
127  III,    10.  1.  3    |             Roland EJ, Moore-Gurrera M (1997): Issues in the linkage
128  III,    10.  1.  3    |                Tremblay A, Blundell JE (1997): Effects of exercise on
129  III,    10.  2.  1    |                  Eur Heart J, 1998; 19: 1997-1207.~ ~Kunst AE, Giskes
130  III,    10.  2.  1    |              market's value. During the 1997-2004 period, growth was
131  III,    10.  2.  1    |               35.7% in 1992 to 39.4% in 1997, but then decreased to 36.
132  III,    10.  2.  1    |                Bostrom and Diderichsen, 1997; Niedhammer et al, 2000).
133  III,    10.  2.  1    |                Adult Nutrition Survey~ ~1997~2015~19-65~24-hour recall~
134  III,    10.  2.  1    |      Consumption Survey (NSIFCS)~NSIFCS~1997-1999~1379~18-64~Individual
135  III,    10.  2.  1    |                Adult Nutrition Survey~ ~1997~2094~19-65~24-hour recall~
136  III,    10.  2.  1    |             survey among adults~NORKOST~1997~2672~16-79~Food Frequency
137  III,    10.  2.  1    |             intakes in Sweden~RIKSMATEN~1997-1998~1210~17-79~Individual
138  III,    10.  2.  1    |                 W, Pearson M. Riksmaten 1997-98. Dietary habits and nutrient
139  III,    10.  2.  1    |              nutrient intakes in Sweden 1997-98. www.livsmedelsverket.
140  III,    10.  2.  1    |                Consumption Survey~DNFCS~1997-1998~4285~19-64~Individual
141  III,    10.  2.  1    |                 Trichopolou and Lagiou, 1997). DAFNE focuses on the creation
142  III,    10.  2.  1    |                Trichopoulou and Lagiou, 1997). Data from 5 additional
143  III,    10.  2.  1    |              project (Riboli and Kaaks, 1997) is one of the few studies
144  III,    10.  2.  1    |             Institute of Public Health, 1997). A similar figure was found
145  III,    10.  2.  1    |          Managing the Global Epidemic” (1997)~· European Council Resolution
146  III,    10.  2.  1    |               Bostrom G, Diderichsen F (1997): Socioeconomic differentials
147  III,    10.  2.  1    |             Institute of Public Health (1997): Determinants of the burden
148  III,    10.  2.  1    |             Institute of Public Health, 1997; quoted from: Food and health
149  III,    10.  2.  4    |                and recommendations, the 1997 UNESCO Declaration on the
150  III,    10.  2.  4    |               and Human Rights (UNESCO, 1997), the 2003 UNESCO International
151  III,    10.  2.  4    |             Data (UNESCO, 2003) and the 1997 Council of Europe Convention
152  III,    10.  2.  4    |         Biomedicine (Council of Europe, 1997) are the most cited. None
153  III,    10.  2.  4    |               544.~ ~Council of Europe (1997): Convention for the protection
154  III,    10.  2.  4    |                159:2249-2256.~ ~UNESCO (1997): Universal Declaration
155  III,    10.  2.  4    |                Genome and Human Rights, 1997, www ~ ~UNESCO (2003): International
156  III,    10.  3.  2    |                human milk, Sweden, 19721997~ ~The most systematic information
157  III,    10.  4.  2    |              human~milk increased until 1997,~after which it declined~ ~
158  III,    10.  4.  2    |              1994, and led in September 1997 to exposure of workers and
159  III,    10.  4.  2    |               soil (European Community, 1997) is ongoing; the first public
160  III,    10.  4.  2    |                 Community before 15 May 1997. Regulation EC 258/97 of
161  III,    10.  4.  2    |                 EC 258/97 of 27 January 1997 of the European Parliament
162  III,    10.  4.  2    |                on Novel Foods on 15 May 1997, are on the EU market under
163  III,    10.  4.  2    |                    European Commission (1997): Regulation No. 258/97/
164  III,    10.  4.  2    |               the Council of 27 January 1997 concerning novel foods and
165  III,    10.  4.  2    |      Communities No. L 043, 14 February 1997. Available at:~htt ~ ~European
166  III,    10.  4.  2    |                    European Commission (1997): Guidance Document on Persistence
167  III,    10.  4.  2    |                 97/78/EC of 18 December 1997 laying down the principles
168  III,    10.  5.  1    |          voluntary reporting system. In 1997, a new monitoring system
169  III,    10.  5.  1    |               teachers health (Norbäck, 1997). Violence and accidents
170  III,    10.  5.  1    |            school environment (Norbäck, 1997).~ ~Moreover, classroom
171  III,    10.  5.  1    |                 135-142.~ ~Norback JP, (1997): Natural Language Computer
172  III,    10.  5.  2    |           defined (Johnson-Webb et al., 1997), and needs to consider
173  III,    10.  5.  2    |              asthma (Jones and Bentham, 1997) and thrombolysis (Rawles
174  III,    10.  5.  2    |                 KD, Baer LD, Gesler WM (1997): What is rural? Issues
175  III,    10.  5.  2    |                    Jones A, Bentham G. (1997): Health service accessibility
176  III,    10.  5.  3    |       participation in employment since 1997.~· In Denmark, Estonia,
177  III,    10.  6.  2    |           Acheson inquiry, appointed in 1997, that reviewed the current
178   IV,    11.  1.  5    |         seriously harmful (Lesar et al, 1997). Preventable adverse reactions
179   IV,    11.  3.  2(3) |         available data for the UK after 1997~
180   IV,    11.  5.  6    |            Oviedo Convention adopted in 1997 by the Council of Europe
181   IV,    11.  5.  6    |             European consensus document~1997Recom 16 on liver transplantation
182   IV,    11.  5.  6    |              from living related donors~1997Recom 15 on xenotransplantation~
183   IV,    11.  6.  2    |                 Spain or England (since 1997), and there are no tax benefits
184   IV,    11.  6.  2    |           expenditure in 1992 to 21% in 1997 (Balabanova, 2002). And
185   IV,    11.  6.  3    |        households (11.3%) (Glennerster, 1997). In examining the tax system
186   IV,    11.  6.  3    |               retired people (Hinrichs, 1997). However, it is argued
187   IV,    11.  6.  3    |                and Barer, 1995; Creese, 1997). Furthermore, international
188   IV,    11.  6.  4    |                and satisfaction” (Kane, 1997).~Indeed, the outcome of
189   IV,    11.  6.  5    |           University Press.~ ~Creese A (1997): "User fees: they don't
190   IV,    11.  6.  5    |               189-206.~ ~Glennerster H (1997): Paying for Welfare: towards
191   IV,    11.  6.  5    |        Political Science.~ ~Hinrichs K (1997): Social Insurances and
192   IV,    11.  6.  5    |                 TS, Briceland L et al. (1997): "Factors Related to Errors
193   IV,    11.  6.  5    |                1(Doc09).~ ~Kane, R. L. (1997). Understanding Health Care
194   IV,    11.  6.  5    |                 Aspen Publishers, Inc., 1997~ ~Rothman KJ, Greenland,
195   IV,    12.  1        |          competence was strengthened in 1997 with the Amsterdam Treaty
196   IV,    12. 10        |           increased significantly since 1997 from €3.67 billion to over €
197   IV,    12. 10        |             Pensioners (EKAS); law 2556/1997 enlarged the group of the